Total Payments
$5,005
2024 Payments
$402.55
Companies
25
Transactions
279
Medicare Patients
10,201
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$4,876 (97.4%)
Education$129.94 (2.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,876 | 276 | 97.4% |
| Education | $129.94 | 3 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,109 | 71 | $0 (2024) |
| Philips Electronics North America Corporation | $1,008 | 100 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $915.21 | 20 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $287.82 | 22 | $0 (2021) |
| Genentech USA, Inc. | $276.09 | 16 | $0 (2019) |
| JAZZ PHARMACEUTICALS INC. | $264.91 | 3 | $0 (2021) |
| Philips North America LLC | $163.74 | 17 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $130.00 | 1 | $0 (2021) |
| Actelion Pharmaceuticals US, Inc. | $127.99 | 1 | $0 (2017) |
| Neurocrine Biosciences, Inc. | $121.18 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $402.55 | 37 | Philips North America LLC ($163.74) |
| 2023 | $448.99 | 55 | Philips Electronics North America Corporation ($266.73) |
| 2022 | $1,399 | 67 | Philips Electronics North America Corporation ($567.37) |
| 2021 | $1,156 | 50 | GlaxoSmithKline, LLC. ($270.26) |
| 2020 | $83.48 | 6 | Boehringer Ingelheim Pharmaceuticals, Inc. ($56.34) |
| 2019 | $813.96 | 38 | Genentech USA, Inc. ($239.97) |
| 2018 | $116.12 | 8 | BOSTON SCIENTIFIC CORPORATION ($59.59) |
| 2017 | $585.31 | 18 | AstraZeneca Pharmaceuticals LP ($140.86) |
All Payment Transactions
279 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $11.35 | General |
| Category: Medical Device | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $7.24 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $11.68 | General |
| Category: Medical Device | ||||||
| 11/14/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $3.19 | General |
| Category: Medical Device | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $4.63 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $12.39 | General |
| Category: Medical Device | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: IMMUNOLOGY | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.04 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $3.46 | General |
| Category: IMMUNOLOGY | ||||||
| 09/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $7.25 | General |
| Category: Medical Device | ||||||
| 08/15/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: IMMUNOLOGY | ||||||
| 08/07/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $14.38 | General |
| Category: Medical Device | ||||||
| 07/29/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $78.99 | General |
| Category: Immunology | ||||||
| 07/25/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: IMMUNOLOGY | ||||||
| 07/09/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $12.83 | General |
| Category: Medical Device | ||||||
| 07/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: RESPIRATORY | ||||||
| 06/06/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $9.57 | General |
| Category: Medical Device | ||||||
| 06/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.71 | General |
| Category: RESPIRATORY | ||||||
| 05/22/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: IMMUNOLOGY | ||||||
| 05/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.78 | General |
| Category: RESPIRATORY | ||||||
| 05/01/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $10.76 | General |
| Category: Medical Device | ||||||
| 05/01/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $8.40 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 2,106 | 3,118 | $972,150 | $254,714 |
| 2022 | 14 | 2,396 | 3,529 | $609,936 | $287,179 |
| 2021 | 21 | 2,952 | 4,075 | $570,450 | $324,281 |
| 2020 | 17 | 2,747 | 3,711 | $461,625 | $269,181 |
Total Patients
10,201
Total Services
14,433
Medicare Billing
$1.1M
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 672 | 1,635 | $613,170 | $174,065 | 28.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 278 | 282 | $54,310 | $14,037 | 25.8% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 271 | 276 | $52,644 | $13,222 | 25.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 70 | 70 | $48,450 | $12,679 | 26.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 276 | 282 | $53,820 | $9,622 | 17.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 98 | 108 | $28,020 | $8,356 | 29.8% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 219 | 223 | $29,720 | $6,431 | 21.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $15,435 | $3,901 | 25.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 31 | 37 | $13,855 | $3,658 | 26.4% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 38 | 40 | $27,810 | $3,144 | 11.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 14 | $6,960 | $2,144 | 30.8% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 12 | 12 | $5,160 | $1,538 | 29.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 11 | 14 | $3,865 | $1,086 | 28.1% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 30 | 30 | $5,726 | $298.20 | 5.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 29 | 33 | $6,705 | $281.49 | 4.2% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 30 | 34 | $6,500 | $250.92 | 3.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 710 | 1,772 | $361,090 | $187,303 | 51.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 126 | 126 | $39,560 | $21,818 | 55.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 304 | 313 | $33,270 | $15,843 | 47.6% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 299 | 308 | $32,171 | $14,535 | 45.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 308 | 317 | $44,470 | $10,912 | 24.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 106 | 134 | $25,640 | $10,174 | 39.7% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2022 | 48 | 51 | $14,190 | $7,176 | 50.6% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 229 | 235 | $20,420 | $6,607 | 32.4% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2022 | 54 | 56 | $25,145 | $4,967 | 19.8% |
About Dr. Jeffrey Lipper, M.D
Dr. Jeffrey Lipper, M.D is a Pulmonary Disease healthcare provider based in Manahawkin, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679512891.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Lipper, M.D has received a total of $5,005 in payments from pharmaceutical and medical device companies, with $402.55 received in 2024. These payments were reported across 279 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($4,876).
As a Medicare-enrolled provider, Lipper has provided services to 10,201 Medicare beneficiaries, totaling 14,433 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Manahawkin, NJ
- Active Since 06/05/2006
- Last Updated 09/29/2010
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679512891
Products in Payments
- (8874) inCourage (Device) $1,067
- TRELEGY ELLIPTA (Drug) $592.69
- NUCALA (Biological) $474.33
- FASENRA (Biological) $288.80
- OFEV (Drug) $226.41
- DUPIXENT (Biological) $223.93
- FASENRA (Drug) $179.97
- BREZTRI (Drug) $179.30
- SUNOSI (Drug) $144.62
- BEVESPI AEROSPHERE (Drug) $140.86
- OPSUMIT MACITENTAN (Drug) $127.99
- INGREZZA (Drug) $121.18
- XYWAV (Drug) $120.29
- TEZSPIRE (Biological) $111.43
- (AK6) Vest Therapy (Device) $104.98
- WATCHMAN (Device) $95.37
- Esbriet (Biological) $94.32
- GLASSIA (Biological) $93.10
- ORENITRAM (Drug) $64.97
- Xolair (Biological) $61.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.